| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mallinckrodt plc | Director | Ordinary Shares | 787 | $72.8K | $92.50 | Jul 31, 2025 | Direct |
| Mereo BioPharma Group plc | Director | Share Options (Right to buy) | 55K | $55.6K | $1.01 | Feb 5, 2025 | Direct |
| Mereo BioPharma Group plc | Director | Deferred Restricted Stock Units | 13.7K | Feb 5, 2025 | Direct | ||
| Mallinckrodt plc | Director | Restricted Stock Units | 5.42K | Oct 20, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| Mallinckrodt plc | Oct 20, 2025 | 1 | $0 | 4 | Oct 20, 2025 | Director | |
| Mallinckrodt plc | Aug 14, 2025 | 1 | $0 | 4 | Aug 18, 2025 | Director | |
| Mallinckrodt plc | Jul 31, 2025 | 0 | $0 | 3 | Aug 4, 2025 | Director | |
| MREO | Mereo BioPharma Group plc | Feb 5, 2025 | 2 | $0 | 4 | Feb 6, 2025 | Director |
| MREO | Mereo BioPharma Group plc | Feb 8, 2024 | 2 | $0 | 4 | Feb 9, 2024 | Director |
| MREO | Mereo Biopharma Group plc | Jan 1, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Director |